Fund
  • 1. Operating Funds

    Limited partners from domestic government institutions, financial institutions, companies,
    and high-net-worth investors

  • Venture Capital

    36

  • Private Equity Fund

    2

  • AUM

    490.7bn

  • ■ Blind Funds : 19 Funds, AUM KRW 400bn
  • ■ Project Funds : 17 Funds, AUM KRW 68.2bn
  • ■ PEF : 2 Funds, AUM KRW 22.5bn
  • 2. Liquidated Funds : 9 Liquidated Funds with Multiple 2.93, IRR 21%
  • Fund Name Established Amount Established Date Liquidation Date IRR
    K& FutureTech No.1 KRW 4.25bn2020-07-172022-12-15 Multiple 1.93 / IRR 35.8%
    K& FutureTech No.6KRW 2.22bn2021-09-01 2022-12-15 Multiple 1.50 / IRR 42.2%
    K& Bio No.1 KRW 3.2bn 2021-10-062023-12-21 Multiple 1.15 / IRR 6.9%
    K& Secondary No.4KRW 6.0bn2020-10-21 2023-12-21 Multiple 1.31 / IRR 10.4%
    K& Digital Contents No.2KRW 2.0bn2017-03-072024-04-12Multiple 1.02 / IRR 0.5%
    K& Secondary No.5KRW 4.5n 2021-12-162025-12-29Multiple 1.02 / IRR 0.5%
    K& Secondary No.3KRW 4.0bn2016-04-262026-04-10Multiple 6.90 / IRR 28.3%
    K& Secondary No.1KRW 5.1bn2017-07-112026-04-21Multiple 1.73 / IRR 6.4%
    IBKC-K& Secondary No.1KRW 19bn2017-09-292026-05-31Multiple 4.27 / IRR 29.7%
    K& Global New Drug Privite Equity Fund No.2KRW 15.6bn 2018-12-19--
    K& No.1 Private Equity Investment LimitedKRW 6.9bn 2020-09-11 --
    K& Secondary No.2KRW 3.0bn2016-12-14--
    K& FutureTech No.5KRW 4.5bn2021-06-25--
    K& Future Mobility No.1 FundKRW 2.65bn2023-04-11--
    K& Future Mobility No.2 FundKRW 3.8bn2024-10-29--
    K& Future Mobility No.3 FundKRW 10.1bn2025-04-21--